Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical research

Adjuvant chemotherapy for non-small-cell lung carcinoma (NSCLC) is a debated issue in clinical oncology. Although it is considered a standard for resected stage II-IIIA patients according to the available guidelines, many questions are still open. Among them, it should be acknowledged that the treat...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Bonomi, Maria, Pilotto, Sara, Milella, Michele, Massari, Francesco, Cingarlini, Sara, Brunelli, Matteo, Chilosi, Marco, Tortora, Giampaolo, Bria, Emilio
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2011
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3284429/
https://ncbi.nlm.nih.gov/pubmed/22206620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-30-115
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki